First Published Case of Alzheimer's Biomarker Reversal in a Chronic Lyme Disease Patient Using Dapsone Combination Therapy

Peer-reviewed findings published in the Journal of Alzheimer's Disease Reports show a 63% reduction in phosphorylated tau after a nine-week oral protocol HYDE PARK, N.Y., April 27, 2026 /PRNewswire/ -- Richard I. Horowitz, MD, and the MSIDS Research Foundation published findings today in...